On a spree, Astel­las bags a next-gen, Park­er-backed CAR-T plat­form with $665M buy­out deal

A lit­tle more than a year af­ter the Park­er In­sti­tute swooped in with an eq­ui­ty in­vest­ment for South San Fran­cis­co-based Xyphos Bio­sciences’ sec­ond-gen CAR-T plat­form …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER